About Us

Kreative Organics Private Limited is a manufacturer of Active Pharmaceutical Ingredients (APIs) for the world market. Kreative started operations in 1990.

Kreative was established by Dr. S. Krishnamohan. Dr. Krishnamohan was formerly with TIFR, BARC, Caltech and NASA. He is a scientist of international repute and runs Kreative with professionalism and a focus on innovation.

Kreative maintains strict quality standards and has developed a robust quality system around which all of our products are manufactured.

Kreative invested in a state of the art cGMP facility in 2005 and expanded it to a US FDA class facility in 2013.

Kreative, is WHO GMP certified and has been successfully been audited by the US FDA in April/May of 2014.

Kreative, which started with one product, today has a portfolio of over 11 products. All of our products were developed by our in-house R&D team. Kreative continues to invest in R&D to develop products for which we can become the supplier of choice for the regulated and quality conscious markets.

These products are exported to regulated markets like USA and Europe and quality conscious customers in markets like Russia, Singapore, Brazil, Taiwan, Korea, etc. Kreative is proud to be the API supplier to some of the world’s largest pharmaceutical companies including Boehringer Ingelheim, Abbott, Actavis, Adcock, Sun Pharmaceuticals, Dr. Reddy’s, Emcure, Cipla, Zydus Cadila, Aurobindo, etc.


  • tea
  • table

The Management Team & Board

Dr. S Krishnamohan

Chairman of the Board and Managing Director

Dr. S. Krishnamohan founded Kreative Organics in 1990. Prior to promoting this company Dr. S. Krishnamohan worked as a scientist with highly reputed institutions like the Tata Institute of Fundamental Research (TIFR) in Bombay, the California Institute of Technology in Pasadena and NASA, USA. Apart from bringing him international reputation, the work as a scientist has sharpened his R&D acumen. This helped tremendously in making Kreative an R&D focused company.

 
Ravi Seelamsetty

Chief Executive Officer (CEO)

Ravi Seelamsetty is an enthusiastic and seasoned organization builder with strong leadership, operations and sales skills. Ravi has vast strategic sales experience and has lead sales and marketing teams in both the US and India. Ravi has a bachelor’s degree from Osmania University, Hyderabad and a master’s degree from the University of Michigan, Ann Arbor.

 
Bala Bhaskara Rao Tummala

Chief Operating Officer (COO)

Bala Bhaskar holds a Master’s Degree in Science (Org. Chemistry). He has about 21 years of vast experience in the pharmaceutical industry. He has versatile experience in all facets of Phamra industry ranging from Research and Development (R&D), Project Development , Execution to Commercial closures, Business Development responsibilities include all new products, in-licensing and alliances, Regulatory Affairs, Manufacturing, Quality and Supply Chain managements, Imports and Exports. He is a certified Independent auditor for Quality Control & Regulatory Affairs. Prior to joining Kreative Organics in 2017, Mr. Bala Bhaskara Rao was the Managing Director of M/s Kalvik Laboratories Private Limited, API Manufacturing Facility located in Hyderabad.

 
Prasad Kandasani

General Manager- Regulatory Affairs

Prasad Kandasani is a post graduate in chemistry with specialization of Foods, Drugs and Wateranalysis from Andhra University Campus. He has 14 years of professional experience in the field ofquality assurance and regulatory affairs functions in high profile pharmaceutical industries. Prior toKreative Organics, he was associated with Dr. Reddy’s, Watson Pharma Private Limited, Sai LifeSciences and Hetero Labs Limited.His professional expertise includes strategic drug development concepts fulfilling both traditionaland enhanced approaches, regulatory change management, ensure customer delight by providingon-time support, high quality regulatory drug mater files submissions to various regulatory agencieslike USFDA, TGA, Health Canada, EDQM and other EU regional countries.He is familiar for application of current regulatory concepts as part of organizational integral qualityand regulatory strategies for faster approval of dependent drug submissions.

Strategy

  • Introducing new products utilizing market inputs from key partners
  • Become a reliable second source for formulators
  • Find new markets for existing products
  • Leveraging and growing our agent network in all markets
  • Continuously finding ways to lower costs for our customers
  • Capture market share by providing technical inputs needed for registration of products.